Work

Poster: MPN-141 Retrospective Comparison of Patient Outcomes on Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia

Year: 2022

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)00960-0

Authors: Claire Harrison, Prithviraj Bose, Ruben Mesa, Aaron Gerds, Stephen Oh, Jean-Jacques Kiladijan, Valentin Garcia-Gutierrez, Alessandro Vannucchi, Christof Scheid, Marta Sobas, Srdan Verstovsek, Sarah Buckley, Karisse Roman-Torres, John Mascarenhas

Institutions: Guy's and St Thomas' NHS Foundation Trust, The University of Texas MD Anderson Cancer Center, Mays Cancer Center at UT Health San Antonio, Cleveland Clinic, Washington University in St. Louis, Université Paris Cité, Hôpital Saint-Louis, Hospital Universitario Ramón y Cajal, Azienda Ospedaliero-Universitaria Careggi, University of Florence, University of Cologne, Wroclaw Medical University, CTI BioPharma (United States), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4296530667

FWCI:

Cites:

Cited by:

Related to: 10